Dated disclosed rounds · latest 2024-01-01
Series B
Pheon Therapeutics
Antibody-drug conjugates (oncology)
- Companies House
- 09677410
- GLEIF LEI
- Not matched
- Latest evidence
- 2024-01-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-01
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
3 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
FundingSource fact Series B
£95.7M / $118.95M · 1 named investor
RegistryRegistry fact Company incorporated
PHEON THERAPEUTICS LTD · company 09677410
Latest disclosed round
Series B
- Date
- 2024-01-01
- Amount
- GBP 95.7m
- Sector
- Biotech & techbio
- Companies House
- 09677410
- ONS region
- North West
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
0 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
No investor relationship retained.
Funding record
1 disclosed round
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2024-01-01 | Series B | £95.7M / $118.95M | 1 additional source-listed name | Labiotech ↗ |
Companies House status and filing snapshot
PHEON THERAPEUTICS LTD
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2015-07-08
- Dissolved
- Not applicable
- Company number
- 09677410
Filing context
- Accounts category
- TOTAL EXEMPTION FULL
- Accounts made up to
- 2025-03-31
- Next accounts due
- 2026-12-31
- Confirmation made up to
- 2026-06-25
- Registry snapshot
- 2026-08-01
- Live check
- Bulk snapshot only
Former registered names: FEMTOGENIX LTD
Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.